rf gpm software version 11.4 Search Results


device name brillian  (JVC Professional)
90
JVC Professional device name brillian
Device Name Brillian, supplied by JVC Professional, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/device+name+brillian/us10067471-217-76-87
Average 90 stars, based on 1 article reviews
device name brillian - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
auditory brain stem evoked responses (abr) for 11.4/s rarefaction clicks  (Nicolet Biomedical)
90
Nicolet Biomedical auditory brain stem evoked responses (abr) for 11.4/s rarefaction clicks
Auditory Brain Stem Evoked Responses (Abr) For 11.4/S Rarefaction Clicks, supplied by Nicolet Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/auditory+brain+stem+evoked+responses++abr++for+11+4+s+rarefaction+clicks/pm10601073-250-13-15
Average 90 stars, based on 1 article reviews
auditory brain stem evoked responses (abr) for 11.4/s rarefaction clicks - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
promis-pf  (ProMIS Neurosciences)
90
ProMIS Neurosciences promis-pf
Influence of modifiable factors on functional outcomes. Firstly, high BMI and obesity are associated with worse scores on quality of life scales, indicating a negative impact ( a ). However, no significant correlation is found between being overweight and functional scores ( b ). Additionally, smokers present greater disability in functional outcomes ( c ), suggesting a detrimental effect of smoking. On the other hand, no significant differences are observed in syndesmosis involvement when assessed by <t>OMAS,</t> <t>SF-36,</t> <t>TUG,</t> or AOFAS ( d , e ). Syndesmosis (1) included OMAS and SF-36 scales. Syndesmosis (2) included TUG or AOFAS scales.
Promis Pf, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/promis+pf/pmc10932135-66-28-21
Average 90 stars, based on 1 article reviews
promis-pf - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
gammacore (electrocore, usa)  (electroCore LLC)
90
electroCore LLC gammacore (electrocore, usa)
Characterization of the studies included in the systematic review (comparable pain outcomes).
Gammacore (Electrocore, Usa), supplied by electroCore LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/gammacore/pmc11309651-11-22-23
Average 90 stars, based on 1 article reviews
gammacore (electrocore, usa) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
golddott  (Derby Spezialfutter GmbH)
90
Derby Spezialfutter GmbH golddott
Characterization of the studies included in the systematic review (comparable pain outcomes).
Golddott, supplied by Derby Spezialfutter GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/golddott/pmc11615265-122-16-17
Average 90 stars, based on 1 article reviews
golddott - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
autodock 1.5.4  (AUTODOCK GmbH)
90
AUTODOCK GmbH autodock 1.5.4
Characterization of the studies included in the systematic review (comparable pain outcomes).
Autodock 1.5.4, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/autodock+vina/10__1007_slash_s42452___020___2482___0-89-76-27
Average 90 stars, based on 1 article reviews
autodock 1.5.4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
11.4% formaldehyde  (PanReac AppliChem)
90
PanReac AppliChem 11.4% formaldehyde
Characterization of the studies included in the systematic review (comparable pain outcomes).
11.4% Formaldehyde, supplied by PanReac AppliChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/3+7++formaldehyde/10__2139_slash_ssrn__3997715-90-37-38
Average 90 stars, based on 1 article reviews
11.4% formaldehyde - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
rehabstim fes  (HASOMED GmbH)
90
HASOMED GmbH rehabstim fes
Characterization of the studies included in the systematic review (comparable pain outcomes).
Rehabstim Fes, supplied by HASOMED GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/rehabstim+fes/pmc09124773-42-14-9
Average 90 stars, based on 1 article reviews
rehabstim fes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
test product  (Verum Diagnostica GmbH)
90
Verum Diagnostica GmbH test product
Characterization of the studies included in the systematic review (comparable pain outcomes).
Test Product, supplied by Verum Diagnostica GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/test+product/pmc06835901-133-11-33
Average 90 stars, based on 1 article reviews
test product - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
abrasive grinding wheels edp 61508  (PFERD Inc)
90
PFERD Inc abrasive grinding wheels edp 61508
Characterization of the studies included in the systematic review (comparable pain outcomes).
Abrasive Grinding Wheels Edp 61508, supplied by PFERD Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/abrasive+grinding+wheels+edp+61508/pm15298850-65-16-9
Average 90 stars, based on 1 article reviews
abrasive grinding wheels edp 61508 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cells ml³  (Barents Group LLC)
90
Barents Group LLC cells ml³
Characterization of the studies included in the systematic review (comparable pain outcomes).
Cells Ml³, supplied by Barents Group LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/cells+ml%C2%B3/pmc10215763-251-61-33
Average 90 stars, based on 1 article reviews
cells ml³ - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
abbvie’s 3d regimen  (AbbVie Inc)
90
AbbVie Inc abbvie’s 3d regimen
The frequency of <t> fibrosis </t> stages before (week 0) and after AbbVie’s <t> 3D regimen </t> (week 12).
Abbvie’s 3d Regimen, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rf+gpm+software+version+11%2E4/abbvie+3d+regimen/pmc08432198-147-23-22
Average 90 stars, based on 1 article reviews
abbvie’s 3d regimen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Influence of modifiable factors on functional outcomes. Firstly, high BMI and obesity are associated with worse scores on quality of life scales, indicating a negative impact ( a ). However, no significant correlation is found between being overweight and functional scores ( b ). Additionally, smokers present greater disability in functional outcomes ( c ), suggesting a detrimental effect of smoking. On the other hand, no significant differences are observed in syndesmosis involvement when assessed by OMAS, SF-36, TUG, or AOFAS ( d , e ). Syndesmosis (1) included OMAS and SF-36 scales. Syndesmosis (2) included TUG or AOFAS scales.

Journal: Journal of Clinical Medicine

Article Title: Predictive Factors of Functional Outcomes and Quality of Life in Patients with Ankle Fractures: A Systematic Review

doi: 10.3390/jcm13051188

Figure Lengend Snippet: Influence of modifiable factors on functional outcomes. Firstly, high BMI and obesity are associated with worse scores on quality of life scales, indicating a negative impact ( a ). However, no significant correlation is found between being overweight and functional scores ( b ). Additionally, smokers present greater disability in functional outcomes ( c ), suggesting a detrimental effect of smoking. On the other hand, no significant differences are observed in syndesmosis involvement when assessed by OMAS, SF-36, TUG, or AOFAS ( d , e ). Syndesmosis (1) included OMAS and SF-36 scales. Syndesmosis (2) included TUG or AOFAS scales.

Article Snippet: Additionally, the minimally clinically important difference was recorded for all scales that had clear evidence: 12 points for LEFS, 7.84 for PROMIS-PF, 4.1 for SF-36, 7.5 to 11.4 OMAS, 7 for SMFA, and 3.4 for TUG [ , , , , , ].

Techniques: Functional Assay

Characterization of the studies included in the systematic review (comparable pain outcomes).

Journal: Pain Reports

Article Title: Transcutaneous vagus nerve stimulation effects on chronic pain: systematic review and meta-analysis

doi: 10.1097/PR9.0000000000001171

Figure Lengend Snippet: Characterization of the studies included in the systematic review (comparable pain outcomes).

Article Snippet: Martelletti et al., 2018 , Italy , RCT n = 243 tcVNS × tcVNS sham , 39.2 ± 11.4 , Migraine , gammaCore (electroCore, USA): neck bilaterally , 25 Hz or 0.1 Hz (sham), 60 mA (peak), sine waves, 2-6 min each side within 20 min pain onset, 8 wk , 0-3 pain scale , tcVNS improved pain (0.22 ± 0.08).

Techniques:

The frequency of fibrosis stages before (week 0) and after AbbVie’s 3D regimen (week 12).

Journal: Journal of Clinical Medicine

Article Title: Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C

doi: 10.3390/jcm10173951

Figure Lengend Snippet: The frequency of fibrosis stages before (week 0) and after AbbVie’s 3D regimen (week 12).

Article Snippet: There was a parallel increase in the prevalence of the highest stage of liver fibrosis: from 21.4% before treatment to 11.4% after AbbVie’s 3D regimen ( ).

Techniques:

The value of non-invasive indirect biomarkers of liver fibrosis before and after 3D regimen treatment of HCV in the experienced and naïve groups of patients. ( a ) tests with multiple value changes ( b ) tests with little or no change in value. Exp—treatment experienced group; Naïve—treatment naïve group; 0—start of treatment; 12—12 weeks after start of treatment. The numbers show multiple increases in the groups from baseline (point 0) after 12 weeks of treatment; * statistically significant differences between point 12 and 0 in experienced and naïve group.

Journal: Journal of Clinical Medicine

Article Title: Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C

doi: 10.3390/jcm10173951

Figure Lengend Snippet: The value of non-invasive indirect biomarkers of liver fibrosis before and after 3D regimen treatment of HCV in the experienced and naïve groups of patients. ( a ) tests with multiple value changes ( b ) tests with little or no change in value. Exp—treatment experienced group; Naïve—treatment naïve group; 0—start of treatment; 12—12 weeks after start of treatment. The numbers show multiple increases in the groups from baseline (point 0) after 12 weeks of treatment; * statistically significant differences between point 12 and 0 in experienced and naïve group.

Article Snippet: There was a parallel increase in the prevalence of the highest stage of liver fibrosis: from 21.4% before treatment to 11.4% after AbbVie’s 3D regimen ( ).

Techniques: